Clinical Trials Directory

Trials / Completed

CompletedNCT00477763

Oasys vs. Extreme H20 Xtra 59

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Innovative Medical · Industry
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

To compare the performance of Oasys to Extreme H20 xtra 59 in dry eye contact lens pts who receive Restasis in 1 eye and vehicle (Endura) in the other eye.

Conditions

Interventions

TypeNameDescription
DRUGRestasis, Refresh Endura1. Restasis 0.4ml- (in the eye) instill twice daily in the randomized eye morning and evening 2. Refresh Endura 0.4ml- (in the eye) instill twice daily in the randomized eye morning and evening

Timeline

Start date
2007-05-01
Primary completion
2008-02-01
Completion
2008-02-01
First posted
2007-05-24
Last updated
2008-02-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00477763. Inclusion in this directory is not an endorsement.